Prosecution Insights
Last updated: May 29, 2026
Application No. 16/612,647

METHODS AND SYSTEMS FOR ASSESSING THE PRESENCE OF ALLELIC DROPOUT USING MACHINE LEARNING ALGORITHMS

Non-Final OA §101§112
Filed
Nov 11, 2019
Priority
May 17, 2017 — provisional 62/507,413 +2 more
Examiner
VASSELL, MEREDITH ABBOTT
Art Unit
1687
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Syracuse University
OA Round
6 (Non-Final)
29%
Grant Probability
At Risk
6-7
OA Rounds
0m
Est. Remaining
76%
With Interview

Examiner Intelligence

Grants only 29% of cases
29%
Career Allowance Rate
17 granted / 59 resolved
-31.2% vs TC avg
Strong +47% interview lift
Without
With
+47.2%
Interview Lift
resolved cases with interview
Typical timeline
4y 7m
Avg Prosecution
23 currently pending
Career history
95
Total Applications
across all art units

Statute-Specific Performance

§101
13.9%
-26.1% vs TC avg
§103
67.3%
+27.3% vs TC avg
§102
2.8%
-37.2% vs TC avg
§112
1.6%
-38.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 59 resolved cases

Office Action

§101 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Office Action Overview Claim Status Canceled: 4, 8, 9-15 Pending: 1-3, 5-7, and 16-19 Withdrawn: none Examined: 1-3, 5-7, and 16-19 Independent: 1 Amended: 1, 5 New: 16-19 Allowable: none Objected to: none Rejections applied Abbreviations 112/b Indefiniteness PHOSITA "a Person Having Ordinary Skill In The Art before the effective filing date of the claimed invention" 112/b "Means for" BRI Broadest Reasonable Interpretation 112/a Enablement, Written description CRM "Computer-Readable Media" and equivalent language X 112 Other IDS Information Disclosure Statement 102, 103 JE Judicial Exception X 101 JE(s) 112/a 35 USC 112(a) and similarly for 112/b, etc. 101 Other N:N page:line Double Patenting MM/DD/YYYY date format Priority As detailed in the 03/20/2020 filing receipt, this application is a 371 of PCT/US18/33154, filed 05/17/2018, which claims priority to Provisional Application No. 62/507,413, filed 05/17/2017. At this point in examination, all claims have been interpreted as being accorded the priority date of 05/17/2017. Withdrawal/Revision of Objections and/or Rejections In view of the amendment and remarks received 08/14/2025: • The previous objection to claim 4 is withdrawn. • The previous rejection of claims 4-6 under U.S.C. 112(d) is withdrawn; however a new rejection of claim 5 under U.S.C. 112(d ) is applied. • The previous rejection of claims 1-7, 9, 11, 12, 14, and 15 under U.S.C. 101 is withdrawn; however a new rejection is applied to reflect the amendment. Rejections and/or objections not maintained from previous office actions are withdrawn. The following rejections and/or objections are either maintained or newly applied. They constitute the complete set applied to the instant application. Claim Interpretation-112(f) The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “sample preparer configured to” in claims 1, 5, and 6. The term “sample preparer” is interpreted to mean the part of the system configured to prepare the sample for DNA analysis by receipt, isolation, extraction, separation, purification, amplification, sequencing, and/or generation of sequence data, of the DNA sample. The structure of the sample preparer is sufficiently described in Specification para. [0011-0012], and [0027]. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claims 5 and 6 are rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claims depending from rejected claims are rejected similarly, unless otherwise noted, and any amendments in response to the following rejections should be applied throughout the claims, as appropriate. Claim 5 does not further limit the "sample preparer" of claim 1, as claim 5 recites "the sample preparer is configured to amplify DNA within the sample", and amended claim 1 recites "a sample preparer configured to receive a sample containing an amount of DNA from a plurality of contributors, to amplify the amount of DNA". It is suggested to cancel claim 5, and amend claim 6 to depend from claim 1. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-3, 5-7, and 16-19 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. MPEP 2106 details the following framework to analyze Subject Matter Eligibility: • Step 1: Are the claims directed to a category of statutory subject matter (a process, machine, manufacture, or composition of matter)? (see MPEP § 2106.03) • Step 2A, Prong One: Do the claims recite a judicially recognized exception, i.e. an abstract idea, a law of nature, or a natural phenomenon? (see MPEP § 2106.04(a)). Note, the MPEP at 2106.04(a)(2) & 2106.04(b) further explains that abstract ideas and laws of nature are defined as: • mathematical concepts, (mathematical formulas or equations, mathematical relationships and mathematical calculations); • certain methods of organizing human activity (fundamental economic practices or principles, managing personal behavior or relationships or interactions between people); and/or • mental processes (procedures for observing, evaluating, analyzing/ judging and organizing information). • laws of nature and natural phenomena are naturally occurring principles/ relations that are naturally occurring or that do not have markedly different characteristics compared to what occurs in nature. • Step 2A, Prong Two: If the claims recite a judicial exception under Prong One, then is the judicial exception integrated into a practical application? (see MPEP § 2106.04(d)) • Step 2B: If the claims do not integrate the judicial exception, do the claims provide an inventive concept? (see MPEP § 2106.05) Step 1: Yes, claims 1-3, 5-7, and 16-19 are directed to a system, and therefore to a category of statutory subject matter. (See MPEP § 2106.03). Step 2A, Prong One: Claims 1, 2, 7, and 16-19 recite abstract ideas as follows: Independent claim 1 recites a system programmed to perform mathematical concepts and mental processes of: • implement a dynamic threshold that is calculated on a mean and a standard deviation of any noise in a region flanking each locus of a plurality of loci in the set of sequence data to detect any alleles in the set of sequence data and remove any low-level noise calculated; • apply a forward stutter filter and a reverse stutter filter to the set of sequence data after the dynamic threshold has been implemented; • apply a trimming algorithm to remove any noise that was incorrectly classified when the dynamic threshold is implemented; • detect any incorrectly detected noise at each locus of the plurality of loci in the set of sequence data; • calculating a predicted occurrence of allelic dropout at a given locus by; • assessing the sequence data and using an allelic dropout model (machine learning algorithm) that determines predicted occurrence of allelic dropout based on an amount of total DNA amplified, a peak height, a sequence count, a Phred score, a minimum number of contributors, a peak height ratio, a locus peak height, a locus peak, and a DNA template amount. Claim 2 further limits the mathematical concept of claim 1 in reciting: • a support vector machine algorithm. Claim 7 recites mental processes and/or mathematical concepts of: • considering (assessing) the sequence data in the database representing DNA present in a known sample with predetermined allelic dropout probabilities; • to develop a model for predicting allelic dropout in an unknown sample. Claim 16-19 recites mathematical concepts and mental processes of: • determining the mean and standard deviation of a y-coordinate data using a plurality of inter-locus ranges specified in a locus threshold dictionary and setting the dynamic threshold at four standard deviations above the mean (claim 16) • apply the forward stutter filter and a reverse stutter filter by implementing one of a Gompertz function and an exponential rise to maximum (claim 17) • apply the trimming algorithm by identifying a maximum locus peak and trimming any peak at any other loci in the set of sequence data are not within five percent of a peak height of the maximum locus peak (claim 18). • apply the trimming algorithm by removing any alleles in the set of sequence data having a height that is not within a predetermined percentage of a highest peak in the set of sequence data (claim 19). Claims 1, 2, 7, and 16-19 recite abstract ideas, characterized as mathematical concepts and mental processes, as listed above. Considering the broadest reasonable interpretation (BRI) of the claims, the mathematical concepts recited in claim 1, 2, 7, and 16-19 [e.g., implementing a dynamic threshold that is calculated on a mean and a standard deviation; applying stutter filters and trimming algorithms; detect any incorrectly detected noise; calculating a predicted occurrence of allelic dropout; applying an allelic dropout model including a machine learning algorithm (support vector machine); implementing Gompertz function; etc.] inherently recite mathematical concepts, which may include use of statistical methods and equations such as those disclosed throughout the Specification, and particularly at [0043-0072]. Additionally, the claims are considered to recite mental processes as there is no detail recited which would prevent the performance in the human mind or with pen and paper. When considering the recited mathematical concepts and mental processes, such steps and analysis performed mentally, or with paper and pencil, may take considerable time and effort, and although a general-purpose computer can perform these steps and analysis at a rate and accuracy that can far exceed the mental performance of a skilled artisan, the nature of the activity is essentially the same, and therefore constitutes an abstract idea. Therefore, the claims recite elements that constitute a judicial exception in the form of abstract ideas. (Step 2A, Prong One: Yes.) Step 2A, Prong Two analysis: Because the claims do recite judicial exceptions, direction under Step 2A, Prong Two provides that the claims must be examined further to determine whether they integrate the abstract ideas into a practical application. A claim can be said to integrate a judicial exception into a practical application when it applies, relies on, or uses the judicial exception in a manner that imposes a meaningful limit on the judicial exception. The Step 2A, Prong Two analysis is performed in order to determine if the abstract idea is integrated into a practical application [see MPEP § 2106.04(d) and (d)(I)] by analyzing the additional elements of the claim, alone or in combination, for the following considerations: • an improvement to technology [see MPEP 2106.04(d) & (d)(1); and 2106.05(a)] • a particular therapy/prophylaxis [see MPEP 2106.04(d) & (d)(2); and 2106.05(e)] • a particular machine [see MPEP 2106.04(d) and 2106.05(b)] • a particular transformation [see MPEP 2106.04(d) and 2106.05(c)] • or for applying or using the judicial exception in some other meaningful way beyond generally linking the use of the judicial exception to a particular technological environment [see MPEP 2106.04(d) and 2106.05(e)]. Note: An explanation of a technical improvement may help to overcome a 101 rejection, as discussed at Step 2A/2nd Prong, 1st consideration of the 101 analysis in MPEP 2106.04(d) and (d)(1). Such an improvement requires detailed explanation applicable to all embodiments reasonably within the claim scope. A detailed explanation of the particular improvement may include identification of the technology field, as well as clearly stating the improvement over the technology field. Submitting persuasive arguments supported by any necessary evidence (including showing improvement by comparison to other method(s) of dropout prediction) to demonstrate that one of ordinary skill in the art would understand that the disclosed invention improves technology may be helpful in successfully showing an improvement, and therefore integrating the abstract idea into a practical application. For example, in response to a rejection under 35 U.S.C. 101, an applicant could submit a declaration under § 1.132 providing testimony on how one of ordinary skill in the art would interpret the disclosed invention as improving technology and the underlying factual basis for that conclusion. See MPEP 2106.05(a). Continuing the Step 2A Prong Two analysis, the following additional elements have been identified: Additional elements of data gathering recited in claims 1 and 5-7: Claims 1 and 7 recite the additional elements of receiving data (claim 1 and 7), generating data (claim 1), providing data (claim 1), and/or receiving a sample (claim 1). Claims 1, 5, and 6 recite the additional element of amplifying DNA (claims 1 and 5) and/or amplifying DNA markers (claim 6). Data gathering steps are additional elements which perform functions of inputting, collecting, and outputting the data needed to carry out the abstract idea. These steps are considered insignificant extra-solution activity, and are not sufficient to integrate an abstract idea into a practical application as they do not impose any meaningful limitation on the abstract idea or how it is performed, nor do they provide an improvement to technology [see MPEP § 2106.04(d)(I)]. Additional elements of computer system components and sample preparation devices recited in claims 1, 2, 5-7, and 16-19: Claims 1, 7, and 16-19 recite the additional element of a processor. Claims 1 and 7 recite the additional element of a database. Claims 1 and 3 recite the additional element of an output device and/or monitor. Claims 1, 5, and 6 recite the additional element of a sample preparer. The claims require only generically claimed computer components and generically claimed sample preparation devices, which do not improve computer or sample preparation technology, and do not integrate the recited judicial exception into a practical application [see MPEP § 2106.04(d)(I) and (d)(1); and MPEP § 2106.05(f)]. Claims 1-3, 5-7, and 16-19 have been further analyzed with respect to Step 2A, Prong Two, and no additional elements have been found, alone or in combination, that would integrate the judicial exception into a practical application. (Step 2A, Prong Two, Claims 1-3, 5-7, and 16-19: No). Step 2B analysis: Because the additional claim elements do not integrate the abstract idea into a practical application, the claims are further examined under Step 2B, which evaluates whether the additional elements, individually and in combination, amount to significantly more than the judicial exception itself by providing an inventive concept. An inventive concept is furnished by an element or combination of elements that is recited in the claim in addition to the judicial exception, and is sufficient to ensure that the claim, as a whole, amounts to significantly more than the judicial exception itself (see MPEP § 2106.05). Claims 1-3, 5-7, and 16-19 do not include additional elements that are sufficient to amount to significantly more than the judicial exception because the claims recite additional elements that are well-understood, routine, and conventional. Those additional elements are as follows: Regarding the additional elements of data gathering in claims 1 and 5-7: Receiving data (claim 1 and 7), generating data (claim 1), providing data (claim 1), receiving a sample (claim 1); amplifying DNA (claims 1 and 5); and amplifying DNA markers (claim 6) do not cause the claims to rise to the level of significantly more than the judicial exception. The courts have recognized receiving or transmitting data over a network; storing and retrieving information in memory; using polymerase chain reaction to amplify and detect DNA; analyzing DNA to provide sequence information or detect allelic variants; and amplifying and sequencing nucleic acid sequences, [see MPEP§2106.05(d)(II)], are well-understood, routine, conventional activity when they are claimed in a merely generic manner (e.g., at a high level of generality) or as extra-solution activity. Additionally, Butler et al., (Electrophoresis, vol. 25(10‐11), pages 1397-1412 (2004)), presents a review on use of ABI systems for sequencing and amplifying DNA markers in forensic DNA analysis (entire document). Therefore, the data gathering steps are shown to be routine, well-understood, and conventional in the art, and as a result, do not provide an inventive concept by amounting to significantly more than the judicial exception. Regarding the additional elements of computer system components and sample preparation devices recited in claims 1, 2, 5-7, and 16-19: The processor (claims 1, 7, and 16-19); the database (claims 1 and 7); the output device and/or monitor (claims 1 and 3); and the sample preparer (claims 1, 5, and 6) of a sample preparer are conventional computer and sample preparation components. These conventional components are referred to in a non-specific way in the claims, as well as in specification paragraph [0010], which states “the present invention …is computationally inexpensive and can be performed using conventional hardware, such as standard desktop or laptop computer with off-the-shelf processors”, while [0040] discloses “samples…were amplified (28 cycles) using the PowerPlex Fusion Human DNA amplification kit (Promega Corporation). These samples were previously run on the Applied Biosystems 3100, 3130 and 3500 series of Genetic Analyzers (ThermoFisher Scientific Inc.) across 6 laboratories”. Additionally, Butler et al. details use of the Promega kits (p.1399, table 2) and the Applied Biosystems genetic analysis platforms (entire document) in forensic DNA analysis, showing DNA sample preparation using capillary electrophoresis and PCR (p.1401-1402); genetic data and peak processing software programs and Mac and Windows computers (p.1406, col.1-2); DNA databases (p.1408, col.1). Butler et al. shows the conventionality of these biocomputational DNA sample and data processing systems used in forensic DNA analysis. Therefore, the additional elements of a processor, database, output device, monitor, sample preparer, and sample preparation do not cause the claims to rise to the level of significantly more than the judicial exception as they do not provide an inventive concept. Further regarding the conventionality of additional elements, the MPEP at 2106.05(b) and 2106.05(d) presents several points relevant to conventional computers and data gathering steps in regards to Step 2A Prong 2 and Step 2B, including: • A general purpose computer that applies a judicial exception, such as an abstract idea, by use of conventional computer functions, does not qualify as a particular machine (see 2106.05(b)(I)), as in the case of claims 1, 2, 5-7, and 16-19, which are interpreted to recite conventional computer components and sample preparers. • Integral use of a machine to achieve performance of a method may integrate the recited judicial exception into a practical application or provide significantly more, in contrast to where the machine is merely an object on which the method operates, which does not integrate the exception into a practical application or provide significantly more (see 2106.05(b)(II). In the instant claims, the recited processor of claims 1, 7, and 16-19 is used in calculating a predicted occurrence of any allelic dropout method; here, the processor acts only as a tool to perform (or which is programmed to perform) the calculation. • Use of a machine that contributes only nominally or insignificantly to the execution of the claimed method (e.g., in a data gathering step or in a field-of-use limitation) would not integrate a judicial exception or provide significantly more (see 2106.05(b)(III). The processor and the sample preparer performing data gathering, outputting, and DNA amplification steps (such as recited in claims 1 and 5-7) do not impose meaningful limitations on the claims. • The courts have recognized “analyzing DNA to provide sequence information or detect allelic variants”; “receiving or transmitting data over a network”, “performing repetitive calculations”, “amplifying and sequencing nucleic acid sequences”, and “storing and retrieving information in memory”, as well-understood, routine, and conventional functions when they are claimed in a merely generic manner (e.g., at a high level of generality) or as insignificant extra-solution activity (see MPEP 2106.05(d)(II)). The obtaining of data and/or the amplification of DNA in claims 1 and 5-7, are recited in a generic manner. All the limitations of claims 1-3, 5-7, and 16-19 have been analyzed with respect to Step 2B, and none provide a specific inventive concept, as they all fail to rise to the level of significantly more than the identified judicial exception, and thus do not transform the judicial exception into a patent eligible application of the exceptions. Step2B: NO. Therefore, the claims, when the limitations are considered individually and as a whole, are rejected under 35 U.S.C. § 101 as being directed to non-statutory subject matter. Response to Applicant Arguments - 35 USC § 101 The Applicant's arguments filed 08/14/2025 have been fully and respectfully considered but they are not yet persuasive. The Applicant asserts on p.7-8: • “…the present claim language does not recite any mathematic concepts because the claims merely rely on underlying calculations or relationships”, (p.7) • “The Examples in the Guidance routinely find that apparatus claims that recite operations that are mathematical in nature but not directed to the mathematical concepts itself, are patent eligible.” (p.8). Applicant's remarks and argument appear to relate to 101 analysis Step 2A, Prong One regarding whether the claim is directed to a Judicial Exception. The arguments are not yet persuasive because claim 1 is explicitly directed to mathematical concepts in reciting calculations, which include calculating of: a dynamic threshold using mean and standard deviation, low-level noise, and a predicted occurrence of allelic dropout. Claims 1, 2, and 16-19 are considered to inherently recite further mathematical concepts in the stutter filters, trimming algorithms, machine learning algorithms, and support vector machine, which encompass mathematical analysis of data, and use methods and equations such as those disclosed throughout the Specification, and particularly at [0043-0072]. A claim that recites a mathematical calculation, when the claim is given its broadest reasonable interpretation in light of the specification, will be considered as falling within the "mathematical concepts" grouping. A mathematical calculation is a mathematical operation (such as multiplication) or an act of calculating using mathematical methods to determine a variable or number, e.g., performing an arithmetic operation such as exponentiation. See MPEP§ 2106.04(a)(2)(I)(C). The Applicant further asserts on p. 9: • "Allelic dropout represents a significant problem ‘may lead to erroneous conclusions, and many times lead to inconclusive results,’ which is obviously a significant problem in the field of forensic DNA analysis where proper identification of the contributors to a sample is critical for investigations and prosecutions of criminals. Specification at ¶[0006] Thus, the solving of this problem by the claimed invention, e.g., 'the system predicted dropout correctly 87.60% of the time (3047 correct and 433 incorrect),' is a significant improvement to specific problem in a specific technological field." (Remarks, p. 9). Applicant's remarks and argument appear to relate to the Step 2A, Prong Two, 1st Consideration regarding an explanation of improvement in comparison to the previous state of the technology field. The argument is not yet persuasive because the Applicant has not yet provided a sufficient explanation of improvement over the previous state of the technology field. An explanation of technical improvement may help overcome a 101 rejection, as discussed in MPEP 2106.04(d)(I) and (d)(1), and MPEP 2106.05(a). Regarding the assertion that “the present invention was applied to 3480 sample, the system predicted dropout correctly 87.60% of the time (3047 correct and 433 incorrect)” (as stated in Specification [0092]), this particular assertion of improvement does not include a numerical comparison to other method(s), and thus an improvement over previous technology is unknown. It would be helpful to have a contrasting value for work representative of the previous state of the field with a citation. Arguments and evidence may be extrinsic to the original disclosure, including references available after the priority date, as long as it is clear that an argument applies to a properly supported claim. It is noted that the Specification compares accuracy, precision, and/or recall among different methods at [0075, table 2], [0077, table 4], [0079, table 5], and [0084, table 6]; however, if an improvement is to be asserted in the future, clarification should be made as to which particular method is implemented on the system of the claimed invention (e.g., iLSST-NR, LSST, or another method). As an example, looking at table 5 in paragraph [0079], the performance of eight different methods is tested with a modeled stutter filter and with a stock stutter filter. It is not clear which method tested represents the claimed invention, so that the asserted Step 2A comparison is not yet clear. The disclosure and Applicant’s arguments have been analyzed for a technical explanation of the asserted improvement, to include that the claims reflect the asserted improvement, and it is considered at this time that an improvement to technology has not yet been sufficiently shown by explanation. To reiterate from the Step 2A, Prong Two analysis section above in the 101 rejection, an explanation of a technical improvement may help to overcome a 101 rejection, as discussed at Step 2A/2nd Prong, 1st consideration of the 101 analysis in MPEP 2106.04(d) and (d)(1). Such an improvement requires detailed explanation applicable to all embodiments reasonably within the claim scope. A detailed explanation of the particular improvement may include identification of the technology field, as well as clearly stating the improvement over the technology field. Submitting persuasive arguments supported by any necessary evidence (including showing improvement by comparison to other method(s) of dropout prediction) to demonstrate that one of ordinary skill in the art would understand that the disclosed invention improves technology may be helpful in successfully showing an improvement, and therefore integrating the abstract idea into a practical application. Additionally, in response to a rejection under 35 U.S.C. 101, an applicant could submit a declaration under § 1.132 providing testimony on how one of ordinary skill in the art would interpret the disclosed invention as improving technology and the underlying factual basis for that conclusion. See MPEP 2106.05(a). As further examples, the argument may clearly and adequately explain cause and effect leading to improvement or, for example when such cause and effect explanation is not possible, then may include evidence (e.g. experimental data) comparing a claimed result to conventional results. Also, arguments and evidence may be extrinsic to the original disclosure, including references available after the priority date, as long as it is clear that an argument applies to all embodiments of a properly supported claim. It is suggested that Applicant submit a detailed explanation of improvement to technology for consideration of integration of the judicial exception into a practical application at Step 2A Prong Two. Conclusion No claim is allowed. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Meredith A Vassell whose telephone number is (571)272-1771. The examiner can normally be reached 8:30 - 4:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, KARLHEINZ SKOWRONEK can be reached at (571)272-9047. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /M.A.V./Examiner Art Unit 1687 /G. STEVEN VANNI/Primary patents examiner Art Unit 1686
Read full office action

Prosecution Timeline

Show 8 earlier events
Oct 04, 2024
Response Filed
May 15, 2025
Non-Final Rejection mailed — §101, §112
Aug 14, 2025
Response Filed
Sep 17, 2025
Final Rejection mailed — §101, §112
Mar 17, 2026
Request for Continued Examination
Mar 19, 2026
Response after Non-Final Action
May 19, 2026
Non-Final Rejection mailed — §101, §112
May 27, 2026
Non-Final Rejection mailed — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12620489
METHOD FOR DETERMINING THE RISK TO DEVELOP TYPE 1 DIABETES
6y 4m to grant Granted May 05, 2026
Patent 12609184
METHODS AND COMPOSITIONS FOR IMPROVED MULTIPLEX GENOTYPING AND SEQUENCING
5y 4m to grant Granted Apr 21, 2026
Patent 12585962
NANO COMPUTING DEVICE AND METHOD OF OPERATING NANO COMPUTING DEVICE
4y 10m to grant Granted Mar 24, 2026
Patent 12575793
SELF-LEARNING INPUT FILTER FOR MEDICAL DEVICES
5y 0m to grant Granted Mar 17, 2026
Patent 12562253
SOFT TISSUE MATERIAL CUMULATIVE DAMAGE MODEL FOR REDUCING REPETITIVE STRESS INJURIES IN PERFORMING A PROCESS
5y 2m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

6-7
Expected OA Rounds
29%
Grant Probability
76%
With Interview (+47.2%)
4y 7m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 59 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month